Abstract Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme of folate pathway. Several polymorphisms were reported in MTHFR gene but C677T polymorphism is most studied and it has been reported to be risk factor for several diseases/disorders. The present study was designed to explore the frequency of MTHFR C677T polymorphism in North Indian healthy population. In addition to this a meta-analysis of published articles was also performed to estimate the global prevalence of MTHFR C677T polymorphism. A total of 1000 unrelated healthy subjects were selected for MTHFR C677T polymorphism analysis. Different databases were searched for eligible articles. Prevalence proportion with 95 % CI was used to determine global prevalence of T allele and TT genotype. Metaanalysis was performed by Open meta-analyst. In 1000 blood samples analyzed, the frequency of T allele and TT genotype was 11 and 1 % respectively. Results of the metaanalysis showed that the global prevalence of T allele and TT genotype were 24.0 % (95 % CI 21.7-26.5) and 7.7 % (95 % CI 6.5-8.9) respectively. In sub-group meta-analysis, the lowest frequency of T allele was found in Africans (10.3 %;, and highest in Europeans (34.1 %; 95 % CI 31.9-36.3). The frequency of T allele in the North India is 11 %. The results of the meta-analysis showed that the frequency of the T allele and the TT genotype of C677T is highest in the Caucasian population.
Introduction
Methylenetetrahydrofolate reductase (MTHFR) is a crucial enzyme in folate/homocysteine pathway. It catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methylenetetrahydrofolate, which donates methyl group for the conversion of homocysteine to methionine. MTHFR gene is located at chromosome 1p36.3 [1] . A number of single nucleotide polymorphisms (SNPs) are reported in MTHFR gene but C677T mutation (rs1801133) is the most studied and clinically important. C677T polymorphism lies in exon 4, in which cytosine is replaced by thymine at 677th position, which resulted in an alanine to valine substitution at position 222 in protein (A222V) [2, 3] . C677T mutation was shown to render the enzyme thermolabile [2] . MTHFR enzyme functions as dimer or tetramer and Flavin adenine dinucleotide (FAD) is the cofactor. The C677T mutation changes the secondary structure of the peptide and interactions between monomers. The A ? V mutation increases the rate of dissociation of FAD and loss of FAD is linked to changes in quaternary structure and enzymatic activity reduces [4] [5] [6] . By docking study it is established that the mutant enzyme (222V) has less affinity towards its cofactor FAD than the normal enzyme (222A) [7] . The variant protein loses its cofactor FAD more quickly and has lower stability. C677T polymorphism effect can be suppressed by addition of folate, which causes a higher FAD affinity [8] .
MTHFR C677T polymorphism has been reported as a risk factor for several diseases/disorders such as-Down syndrome [9, 10] , neural tube defects [11] , orofacial clefts [12] , type I diabetes [13] , cardiovascular diseases [2, 14] , male infertility [15] , schizophrenia [16] , bipolar disorder [16] and cancer [17] etc. The frequency of C677T polymorphism has been described from several world populations. But from India very limited case-control studies were published. So, it is very important to know the frequency of such a clinically important gene polymorphism in the healthy Indian population. Together with this the second objective of present study was to estimate the global prevalence of C677T polymorphism by meta-analysis.
Materials and Methods

Random Sample Analysis
Sample Collection 3 ml blood sample was collected in EDTA coated vials from 1000 unrelated healthy subjects which were domicile of Eastern Uttar Pradesh (UP). The study was approved by the Institutional Ethics Committee of the VBS Purvanchal University, Jaunpur. Blood sample was collected after getting informed written consent. Genomic DNA was extracted by the method of Bartlett and White [18] .
Genotyping
MTHFR C677T genotyping was carried out by PCR-RFLP method of Frosst et al. [2] . Briefly 100 ng of genomic DNA was amplified in a final volume of 15 ll with 4 pM of each of forward and reverse primers, 250 ll of dNTPs mix, 1X Taq DNA polymerase buffer and 1u of Taq DNA polymerase. PCR program was initial denaturation at 94°C for 4 min followed by 30 cycles of denaturation at 94°C for 1 min, annealing at 62°C for 1 min, extension at 72°C for 1 min and a final extension at 72°C for 10 min. The amplicons (198 bp) were digested with HinfI as the C677T mutation creates a restriction site for it, and resolved in a 4 % agarose gel. For quality control, 10 % of samples (randomly selected) were re-genotyped and no discrepancy in genotypes were found.
Statistical Analysis
Allele frequencies were calculated by the gene counting method. v 2 test was performed to test the Hardy-Weinberg Equilibrium(HWE). All statistical analysis was performed by DeFinetti program (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl).
Meta-analysis
Searched Strategy and Identification of Studies
For meta-analysis Pubmed, Science Direct, Springer link and Google scholar databases were searched for the suitable articles using keywords ''MTHFR'', ''methylenetetrahydrofolate reductase'', ''C677T''. Large number of articles were retrieved so that only those articles were selected for the inclusion in which C677T polymorphism in healthy subjects were analyzed. The included articles were also hand searched for additional studies which may be included in present meta-analysis.
Inclusion and Exclusion Criteria
The inclusion criteria were as follows: studies should: (1) be original, (2) selected only healthy subjects for C677T analysis and (3) reported MTHFR genotypes. Studies were excluded if they were: (1) case-control, (2) case reports, and (3) review, editorial etc.
Data Extraction
For all the eligible studies following information were extracted: first authors' family name, year of publication, journal name, country name, population/ethnic group, number of alleles and/or genotypes. If in a study samples were taken from multiple countries or different race/caste then information was abstracted separately for each country/race/caste.
Statistical Analysis
Prevalence proportions (PP) was computed from the number of alleles/genotypes and total number of alleles/sample sizes (N) with the corresponding 95 % confidence interval (CI). A pooled PP was then estimated on the basis of the individual PPs. The PP was estimated either by fixed effect [19] or random effect [20] model depending upon heterogeneity. The heterogeneity between studies was tested using the Q-statistics and was quantified using the I 2 statistic [21] . If I 2 [ 50 % then random effect model was used [22] , otherwise fixed effect model was adopted. We have also done sub-group analysis based on geographical area i.e. the region from where the study belonged (Africa, North America, South America, Asia, Australia and Europe). All p values are two tailed with a significance level at \0.05. All statistical analyses were undertaken by Open Meta-analyst [23] .
A global C677T frequency map was created by StatPlanet software [24] by pooling the prevalence of MTHFR C677T gene polymorphism in different countries.
Results
MTHFR C677T Polymorphism Analysis
Total 1000 blood samples were collected from healthy individuals selected from Eastern UP and analyzed for MTHFR C677T polymorphism. The 198 bp long MTHFR amplicon was digested with HinfI and resolved in 2 % agarose gel. The C677T substitution at nucleotide 677 creates a HinfI digestion site. T allele was digested into 2 fragments (175 and 23 bp), whereas C allele remains uncut ( Fig. 1) . In total 1000 samples the number of CC, CT and 
Meta-analysis
Characteristic of Eligible Studies
With our initial search strategy, total 6124 articles were retrieved. After exclusion of reviews, meta-analysis, casecontrol studies, letter to editor, editorials, comments and observational studies etc., 62 articles (investigated 178 populations) with 47,592 samples were found suitable for the inclusion in the present meta-analysis (including present study) (Fig. 2) . In included 62 articles-two articles were published by Australian scientists and they analyzed C677T polymorphism in three populations [25, 26] Table 2) .
Meta-analysis
The meta-analysis showed that the global frequency of T allele was 24.0 % by adopting random effect model (95 % CI 21.7-26.5, p \ 0.001; I 2 = 98.74 %) and 26.0 % (95 % CI 25.8-26.3, p \ 0.001) by fixed effect model. The frequency of TT genotype was 7.7 % (95 % CI 6.5-8.9, p \ 0.001; I 2 = 96.25 %) by random effect model and 6.5 (95 % CI 6.3-6.7, p \ 0.001) by fixed effect model (Table 3) . Between studies heterogeneity was high so random effect model was adopted.
Sub-group Analysis
In sub-group meta-analysis, the frequency of T allele was 10.3 % (95 % CI 3.8-16.8, p = 0.002; I 2 = 92.79 %) and frequency of TT genotype was 2.4 % (95 % CI -0.00 to (Table 3 ; Fig. 3a ), the frequency of T allele was 20.5 % (95 % CI 2.6-38.4, p = 0.02; I 2 = 98.1 %) and frequency of TT genotype was 5.9 % (95 % CI -0.5 to 12.3, p \ 0.071; I 2 = 91.12 %) in Australia (Table 3 ; Fig. 3b ), the frequency of T allele was 27. Fig. 3c ), the frequency of T allele was 34.1 % (95 % CI 31.9-36.3, p \ 0.001; I 2 = 91.08 %) and frequency of TT genotype was 11.6 % (95 % CI 9.9-13.3, p \ 0.001; I 2 = 87.33 %) in Europe (Table 3 ; Fig. 4a ), the frequency of T allele was 31.2 % (95 % CI 25.7-36.7, p \ 0.001; I 2 = 97.58 %) and frequency of TT genotype was 11.9 % (95 % CI 8.8-14.9, p \ 0.001; I 2 = 95.6 %) in North America (Table 3 ; Fig. 4b ), the frequency of T allele was 19.7 % (95 % CI 16.0-23.4, p \ 0.001; I 2 = 99.13 %) and the frequency of TT genotype was 5.5 % (95 % CI 3.7-7.2, p \ 0.001; I 2 = 97.22 %) in Asia (Table 3 ; Fig. 4c ). Heterogeneity was high so random effect model was adopted.
Country-specific prevalence estimates for T allele is presented in Fig. 5a . Visual inspection of the map, revealed the highest prevalence of T allele in China, Mexico and some part of Europe. Same trend are also seen for the TT genotype (Fig. 5b) .
Discussion
The objectives of present study were to determine (1) the frequency of MTHFR C677T polymorphism in Eastern UP population, and (2) the worldwide prevalence of C677T polymorphism by conducting a meta-analysis. MTHFR C677T has a high degree of heterogeneity in its world distribution. T allele is less prevalent in African population, its incidence is intermediate among Asian populations, and it is more prevalent in European and American populations. In present study, the prevalence of the mutant T allele was found as 11 % in the Eastern UP population (1 % TT homozygous) which is similar to that reported earlier from other Indian population. The main strength of this study is that this is the largest study (1000 samples) conducted on healthy individuals from Eastern U P population. The present study has some limitations like-only distribution of genotype in healthy subjects was reported and not presenting an association report. In meta-analysis, global frequency of T allele was found 24.0 %. In subgroup analysis the frequency of T allele was 10.3 % in Africans, 31.2 % in North Americans, 27.8 % in South Americans, 19.7 % in Asians, 20.5 % in Australians and 34.1 % in Europeans. The global frequency of TT genotype was 7.7 %. In subgroup analysis, the frequency of TT genotype was 2.4 % in Africans, 11.9 % in North Americans, 7.6 % in South Americans, 5.5 % in Asians, 5.9 % in Australians and 11.6 % in Europeans. The frequency of both the T allele and TT genotype was lowest in Africans and highest in Europeans. Among Asian studies the frequency of this gene polymorphism was found higher in East Asian countries (44.7 % in China, 40.3 % in Korea, 39.9 % in Japan) than South Asian countries (11.4 % in India, 16 % in Pakistan, 4.5 % in Sri Lanka. The high frequency of T allele in East Asian countries might be due to folate and vitamin B12 rich non-vegetarian food habits of the population. Similarly, in South Asian countries highest frequency of T allele is found in Pakistan where majority of the population is non-vegetarian.
Meta-analysis is a powerful tool for analyzing cumulative data of studies where the individual sample sizes are small. During past decade several meta-analyses were published assessing MTHFR C677T gene polymorphism as risk factor for various diseases/disorders like Down syndrome [86, 87] , cleft lip and palate [88] , cardiovascular disease [89] , diabetes [90] , psychiatric disorder [91] , neural tube defects [92] , cancer [93] etc.
The meta-analysis has a number of strengths-(1) this is the first meta-analysis on the prevalence of MTHFR C677T gene polymorphism and (2) absence of publication bias. However, there are also some limitations-(1) we did not include case-control studies, (2) some studies might have not been included in this meta-analysis due to limitations of searched databases and (3) presence of high heterogeneity.
In conclusion, the frequency of the MTHFR C677T gene polymorphism discriminates the Indian population from other ethnic groups like Africans or Caucasians. Overall, our study showed a varied distribution of MTHFR C677T allele in various ethnic groups residing in diverse geographical regions of the world. The reason for the varied distribution seems to be directed not only by the environmental effect (specially folate and B12 rich/ deficient diet) but also due to diversity in the origin and relatedness of various ethnic groups residing in the world. The aim of the study was to show countrywide prevalence of this highly important gene variant. Since MTHFR C677T polymorphism has been found to be associated with different diseases, the data would be very useful in regional health management programs and will facilitate predicting population-based risk factors for a number of congenital and other anomalies associated with MTHFR polymorphism.
